Who is sponsoring NCT06187246?

NCT06187246 is sponsored by Universidad Rey Juan Carlos.

What drugs are being tested in NCT06187246?

Interventions in NCT06187246: Avatar-based intervention, Individual informative talks.

What condition does NCT06187246 study?

NCT06187246 studies Female Orgasmic Disorder.

Is NCT06187246 still recruiting?

NCT06187246 is currently completed. Last updated 2 January 2024.

Last reviewed 2024-01-02 · How we verify

NCT06187246

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Avatar-based Therapy for Female Orgasmic Disorder

Completed NA Last updated 2 January 2024

What this trial tests

NA trial testing Avatar-based intervention in Female Orgasmic Disorder in 31 participants. Completed in 1 June 2023.

Timeline

1 January 2022

Primary endpoint
1 June 2023

1 June 2023

Quick facts

Lead sponsor	Universidad Rey Juan Carlos
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	31
Start date	1 January 2022
Primary completion	1 June 2023
Estimated completion	1 June 2023
Sites	1 location across Spain

Drugs / interventions tested

Avatar-based intervention
Individual informative talks

Conditions studied

Female Orgasmic Disorder — all drugs for Female Orgasmic Disorder →

Sponsor

Universidad Rey Juan Carlos — full company profile →

Who can join

18 and older, female only, with Female Orgasmic Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized controlled trial was conducted for testing the efficacy of a novel avatar-based intervention (IG), that was compared with a control group (CG) for women with female orgasmic disorder (FOD). Participants were 31 women who were randomly assigned to the intervention or the control conditions. Intervention was based on the cognitive behavioral therapy approach (treatment with the most empirical evidence) and previous literature about FOD. It consisted of 12 weekly online individual sessions and aimed at improving the FOD diagnosis, sexual variables, and variables that are known to affect orgasm consecution. Control group was based on minimum therapeutic contact. Changes over time in the assessed variables were analyzed using linear mixed models, considering treatment group, measurement time point, and group-by-time interactions as fixed effects. Effect sizes were computed (Cohen's d; number needed to treat - NNT; reliable change index - RCI).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Metaverse in Mental Health: The Beginning of a Long History.
Cerasa A, Gaggioli A, Pioggia G, Riva G. · · 2024 · cited 11× · PMID 38602624 · DOI 10.1007/s11920-024-01501-8
Body, emotions, and sexuality in the metaverse: A Randomized Control Trial Exploring the Use of Second Life for an Avatar-based Intervention to support women With Female Orgasmic Disorder
Vila A, Cuadros JA, Romero-Moreno R, Nogales-Gonzalez C, et al · · 2024 · DOI 10.31234/osf.io/qju56

Verify or expand the search:

Other Universidad Rey Juan Carlos trials

Trials by the same sponsor.

NCT07524400 — Effects of Physical Exercise Combined With Transcranial Direct Current Stimulation in Parkinson's Disease · NA · recruiting
NCT07402902 — Caffeine Strategies and Fat Oxidation · NA · not yet recruiting
NCT07251738 — Understanding the Lived Experience and Bereavement of Caregivers of People With Alzheimer's Disease · not yet recruiting
NCT07247760 — PATIENT SATISFACTION AND MASKING OF WHITE SPOT LESIONS AFTER HOME WHITENING WITH 10% CARBAMIDE PEROXIDE · NA · enrolling by invitation
NCT06968676 — Mixed Reality for Upper Limb Rehabilitation in People With Multiple Sclerosis (VIRTUALDOMUS) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06187246 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad Rey Juan Carlos
Last refreshed: 2 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06187246.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing